title: Ranibizumab for subfoveal choroidal neovascularization in Bietti crystalline retinopathy.
authors.forename: V
authors.initials: V
authors.lastname: Le Tien
authors.forename: K
authors.initials: K
authors.lastname: Atmani
authors.forename: G
authors.initials: G
authors.lastname: Querques
authors.forename: N
authors.initials: N
authors.lastname: Massamba
authors.forename: E H
authors.initials: EH
authors.lastname: Souied
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D003460:Crystallization; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D000069579:Ranibizumab; D012164:Retinal Diseases / Q000150:complications*; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab